Viridian Therapeutics
VRDN
VRDN
128 hedge funds and large institutions have $1.12B invested in Viridian Therapeutics in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 69 increasing their positions, 25 reducing their positions, and 24 closing their positions.
Holders
128
Holders Change
-7
Holders Change %
-5.19%
% of All Funds
2.02%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.14%
New
17
Increased
69
Reduced
25
Closed
24
Calls
$11.9M
Puts
$18.8M
Net Calls
-$6.91M
Net Calls Change
-$12.3M
Top Buyers
1 |
B
1
Braidwell
Stamford,
Connecticut
|
$28.7M |
2 |
PCH
2
Polar Capital Holdings
London,
United Kingdom
|
$38.1M |
3 |
3
Millennium Management
New York
|
$31.8M |
4 |
4
State Street
Boston,
Massachusetts
|
$69.4M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$61.8M |